Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India

Vaccine

Volumn 20, Issue 29-30, 2002, Pages 3431-3435

  Murhekar, M V ^a   Murhekar, K M ^a   Arankalle, V A ^b   Sehgal, S C ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

Andaman and Nicobar Islands; Hepatitis B; Hepatitis B vaccine; India; Tribes

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ARTICLE; CHILD; CLINICAL TRIAL; COMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; FEMALE; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INDIA; MALE; NORMAL HUMAN; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; VACCINATION;

EID: 0037019917     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00337-7     Document Type: Article

References (8)

1. Murhekar M.V., Murhekar K.M., Das D., Arankalle V.A., Sehgal S.C. Prevalence of hepatitis-B infection among the primitive tribes of Andaman: prevalence of hepatitis-B infection among the primitive tribes of Andaman & Nicobar Islands. Indian J. Med. Res. 111:2000;199-203.
2. M.V. Murhekar, K.M. Murhekar, V.A. Arankalle, S.C. Sehgal SC, Epidemiology of hepatitis-B infection among the Nicobarese: a mongoloid tribe of Andaman and Nicobar Islands, India, Epid Inf 2002;128(3):465-71.
3. Kumar A., Joshi N., Sreenivas D.V., Palan S., Nagarjunakumar Y.R. Clinical safety and efficacy of first indigenous recombinant hepatitis-B vaccine. J. Assoc. Phys. Ind. 46:1998;620-622.
4. Abraham P., Mistry F.P., Bapat M.R., Sharma G., Reddy G.R., Prasad K.S.N.et al. Evaluation of a new recombinant DNA hepatitis-B vaccine (Shanvac-B). Vaccine. 17:1999;1125-1129.
5. Nagaraja Rao M., Joshi N., Habibullah C.M. Immunogenecity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants. Indian Pediatr. 36:1999;581-583.
6. Zuckerman JN, Harrison TJ, Zuckerman AJ. Prevention. In: Zuckerman AJ, Thomas HC, editors. Viral hepatitis, 2nd ed, London: Churchill Livingstone. p. 245-52.
7. Tandon B.N., Irshad M., Raju M., Mathur G.P., Rao M.N. Prevalence of HBsAg and anti-HBs in children and strategy suggested for immunization in India. Indian J. Med. Res. 93:1991;337-339.
8. Murhekar MV, Murhekar MV, Arankalle VA, Sehgal SC. Changing scenario of HAV and HEV exposure among the primitive tribes of Andaman and Nicobar Islands, India over 10-year period, 1989-1999. J Viral Hepatitis 2002;9:315-21.